Investing.com | Editor Ahmed Abdulazez Abdulkadir
Published Mar 07, 2024 07:30
BASEL, Switzerland - Bruker (NASDAQ:BRKR) Corporation (NASDAQ:BRKR), a global scientific instrumentation company, has finalized the purchase of Chemspeed Technologies AG, a Swiss firm specializing in automated laboratory solutions for research and development (R&D) and quality control (QC). This acquisition, part of Bruker’s Project Accelerate 2.0, aims to enhance its offerings in scientific software and laboratory automation.
The transaction, which was initially announced in January 2024, is expected to contribute approximately $10 million in revenue per quarter for Chemspeed, as it shifts to US GAAP reporting and adapts to Bruker's revenue recognition policies. By 2025, Chemspeed is anticipated to add 2-3 cents to Bruker’s non-GAAP earnings per share (EPS). The company also forecasts organic revenue growth in the high single digits to low double digits and significant margin expansion moving forward.
Bernd Gleixner, President of Bruker BioSpin's Automation Division and now Managing Director of Chemspeed, expressed enthusiasm for the acquisition, emphasizing the continued operation of Chemspeed as a vendor-agnostic entity within Bruker. The focus remains on industry-leading automated laboratory solutions and customer service.
Chemspeed's modular and compact FLEX automation workstations aim to improve productivity and quality in chemical and materials science R&D labs while also enhancing the return on R&D investment.
Bruker Corporation is known for its high-performance scientific instruments and analytical and diagnostic solutions. The company's products support scientific research at molecular, cellular, and microscopic levels across various fields, including life science research, applied and pharmaceutical applications, microscopy, nanoanalysis, and industrial applications.
The information in this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.